45 | 20 | | (a) A contract between a managed care organization and the |
---|
46 | 21 | | commission for the organization to provide health care services to |
---|
47 | 22 | | recipients must contain: |
---|
48 | 23 | | (1) procedures to ensure accountability to the state |
---|
49 | 24 | | for the provision of health care services, including procedures for |
---|
50 | 25 | | financial reporting, quality assurance, utilization review, and |
---|
51 | 26 | | assurance of contract and subcontract compliance; |
---|
52 | 27 | | (2) capitation rates that ensure the cost-effective |
---|
53 | 28 | | provision of quality health care; |
---|
54 | 29 | | (3) a requirement that the managed care organization |
---|
55 | 30 | | provide ready access to a person who assists recipients in |
---|
56 | 31 | | resolving issues relating to enrollment, plan administration, |
---|
57 | 32 | | education and training, access to services, and grievance |
---|
58 | 33 | | procedures; |
---|
59 | 34 | | (4) a requirement that the managed care organization |
---|
60 | 35 | | provide ready access to a person who assists providers in resolving |
---|
61 | 36 | | issues relating to payment, plan administration, education and |
---|
62 | 37 | | training, and grievance procedures; |
---|
63 | 38 | | (5) a requirement that the managed care organization |
---|
64 | 39 | | provide information and referral about the availability of |
---|
65 | 40 | | educational, social, and other community services that could |
---|
66 | 41 | | benefit a recipient; |
---|
67 | 42 | | (6) procedures for recipient outreach and education; |
---|
68 | 43 | | (7) a requirement that the managed care organization |
---|
69 | 44 | | make payment to a physician or provider for health care services |
---|
70 | 45 | | rendered to a recipient under a managed care plan on any claim for |
---|
71 | 46 | | payment that is received with documentation reasonably necessary |
---|
72 | 47 | | for the managed care organization to process the claim: |
---|
73 | 48 | | (A) not later than: |
---|
74 | 49 | | (i) the 10th day after the date the claim is |
---|
75 | 50 | | received if the claim relates to services provided by a nursing |
---|
76 | 51 | | facility, intermediate care facility, or group home; |
---|
77 | 52 | | (ii) the 30th day after the date the claim |
---|
78 | 53 | | is received if the claim relates to the provision of long-term |
---|
79 | 54 | | services and supports not subject to Subparagraph (i); and |
---|
80 | 55 | | (iii) the 45th day after the date the claim |
---|
81 | 56 | | is received if the claim is not subject to Subparagraph (i) or (ii); |
---|
82 | 57 | | or |
---|
83 | 58 | | (B) within a period, not to exceed 60 days, |
---|
84 | 59 | | specified by a written agreement between the physician or provider |
---|
85 | 60 | | and the managed care organization; |
---|
86 | 61 | | (7-a) a requirement that the managed care organization |
---|
87 | 62 | | demonstrate to the commission that the organization pays claims |
---|
88 | 63 | | described by Subdivision (7)(A)(ii) on average not later than the |
---|
89 | 64 | | 21st day after the date the claim is received by the organization; |
---|
90 | 65 | | (8) a requirement that the commission, on the date of a |
---|
91 | 66 | | recipient's enrollment in a managed care plan issued by the managed |
---|
92 | 67 | | care organization, inform the organization of the recipient's |
---|
93 | 68 | | Medicaid certification date; |
---|
94 | 69 | | (9) a requirement that the managed care organization |
---|
95 | 70 | | comply with Section 533.006 as a condition of contract retention |
---|
96 | 71 | | and renewal; |
---|
97 | 72 | | (10) a requirement that the managed care organization |
---|
98 | 73 | | provide the information required by Section 533.012 and otherwise |
---|
99 | 74 | | comply and cooperate with the commission's office of inspector |
---|
100 | 75 | | general and the office of the attorney general; |
---|
101 | 76 | | (11) a requirement that the managed care |
---|
102 | 77 | | organization's usages of out-of-network providers or groups of |
---|
103 | 78 | | out-of-network providers may not exceed limits for those usages |
---|
104 | 79 | | relating to total inpatient admissions, total outpatient services, |
---|
105 | 80 | | and emergency room admissions determined by the commission; |
---|
106 | 81 | | (12) if the commission finds that a managed care |
---|
107 | 82 | | organization has violated Subdivision (11), a requirement that the |
---|
108 | 83 | | managed care organization reimburse an out-of-network provider for |
---|
109 | 84 | | health care services at a rate that is equal to the allowable rate |
---|
110 | 85 | | for those services, as determined under Sections 32.028 and |
---|
111 | 86 | | 32.0281, Human Resources Code; |
---|
112 | 87 | | (13) a requirement that, notwithstanding any other |
---|
113 | 88 | | law, including Sections 843.312 and 1301.052, Insurance Code, the |
---|
114 | 89 | | organization: |
---|
115 | 90 | | (A) use advanced practice registered nurses and |
---|
116 | 91 | | physician assistants in addition to physicians as primary care |
---|
117 | 92 | | providers to increase the availability of primary care providers in |
---|
118 | 93 | | the organization's provider network; and |
---|
119 | 94 | | (B) treat advanced practice registered nurses |
---|
120 | 95 | | and physician assistants in the same manner as primary care |
---|
121 | 96 | | physicians with regard to: |
---|
122 | 97 | | (i) selection and assignment as primary |
---|
123 | 98 | | care providers; |
---|
124 | 99 | | (ii) inclusion as primary care providers in |
---|
125 | 100 | | the organization's provider network; and |
---|
126 | 101 | | (iii) inclusion as primary care providers |
---|
127 | 102 | | in any provider network directory maintained by the organization; |
---|
128 | 103 | | (14) a requirement that the managed care organization |
---|
129 | 104 | | reimburse a federally qualified health center or rural health |
---|
130 | 105 | | clinic for health care services provided to a recipient outside of |
---|
131 | 106 | | regular business hours, including on a weekend day or holiday, at a |
---|
132 | 107 | | rate that is equal to the allowable rate for those services as |
---|
133 | 108 | | determined under Section 32.028, Human Resources Code, if the |
---|
134 | 109 | | recipient does not have a referral from the recipient's primary |
---|
135 | 110 | | care physician; |
---|
136 | 111 | | (15) a requirement that the managed care organization |
---|
137 | 112 | | develop, implement, and maintain a system for tracking and |
---|
138 | 113 | | resolving all provider appeals related to claims payment, including |
---|
139 | 114 | | a process that will require: |
---|
140 | 115 | | (A) a tracking mechanism to document the status |
---|
141 | 116 | | and final disposition of each provider's claims payment appeal; |
---|
142 | 117 | | (B) the contracting with physicians who are not |
---|
143 | 118 | | network providers and who are of the same or related specialty as |
---|
144 | 119 | | the appealing physician to resolve claims disputes related to |
---|
145 | 120 | | denial on the basis of medical necessity that remain unresolved |
---|
146 | 121 | | subsequent to a provider appeal; |
---|
147 | 122 | | (C) the determination of the physician resolving |
---|
148 | 123 | | the dispute to be binding on the managed care organization and |
---|
149 | 124 | | provider; and |
---|
150 | 125 | | (D) the managed care organization to allow a |
---|
151 | 126 | | provider with a claim that has not been paid before the time |
---|
152 | 127 | | prescribed by Subdivision (7)(A)(ii) to initiate an appeal of that |
---|
153 | 128 | | claim; |
---|
154 | 129 | | (16) a requirement that a medical director who is |
---|
155 | 130 | | authorized to make medical necessity determinations is available to |
---|
156 | 131 | | the region where the managed care organization provides health care |
---|
157 | 132 | | services; |
---|
158 | 133 | | (17) a requirement that the managed care organization |
---|
159 | 134 | | ensure that a medical director and patient care coordinators and |
---|
160 | 135 | | provider and recipient support services personnel are located in |
---|
161 | 136 | | the South Texas service region, if the managed care organization |
---|
162 | 137 | | provides a managed care plan in that region; |
---|
163 | 138 | | (18) a requirement that the managed care organization |
---|
164 | 139 | | provide special programs and materials for recipients with limited |
---|
165 | 140 | | English proficiency or low literacy skills; |
---|
166 | 141 | | (19) a requirement that the managed care organization |
---|
167 | 142 | | develop and establish a process for responding to provider appeals |
---|
168 | 143 | | in the region where the organization provides health care services; |
---|
169 | 144 | | (20) a requirement that the managed care organization: |
---|
170 | 145 | | (A) develop and submit to the commission, before |
---|
171 | 146 | | the organization begins to provide health care services to |
---|
172 | 147 | | recipients, a comprehensive plan that describes how the |
---|
173 | 148 | | organization's provider network complies with the provider access |
---|
174 | 149 | | standards established under Section 533.0061; |
---|
175 | 150 | | (B) as a condition of contract retention and |
---|
176 | 151 | | renewal: |
---|
177 | 152 | | (i) continue to comply with the provider |
---|
178 | 153 | | access standards established under Section 533.0061; and |
---|
179 | 154 | | (ii) make substantial efforts, as |
---|
180 | 155 | | determined by the commission, to mitigate or remedy any |
---|
181 | 156 | | noncompliance with the provider access standards established under |
---|
182 | 157 | | Section 533.0061; |
---|
183 | 158 | | (C) pay liquidated damages for each failure, as |
---|
184 | 159 | | determined by the commission, to comply with the provider access |
---|
185 | 160 | | standards established under Section 533.0061 in amounts that are |
---|
186 | 161 | | reasonably related to the noncompliance; and |
---|
187 | 162 | | (D) regularly, as determined by the commission, |
---|
188 | 163 | | submit to the commission and make available to the public a report |
---|
189 | 164 | | containing data on the sufficiency of the organization's provider |
---|
190 | 165 | | network with regard to providing the care and services described |
---|
191 | 166 | | under Section 533.0061(a) and specific data with respect to access |
---|
192 | 167 | | to primary care, specialty care, long-term services and supports, |
---|
193 | 168 | | nursing services, and therapy services on the average length of |
---|
194 | 169 | | time between: |
---|
195 | 170 | | (i) the date a provider requests prior |
---|
196 | 171 | | authorization for the care or service and the date the organization |
---|
197 | 172 | | approves or denies the request; and |
---|
198 | 173 | | (ii) the date the organization approves a |
---|
199 | 174 | | request for prior authorization for the care or service and the date |
---|
200 | 175 | | the care or service is initiated; |
---|
201 | 176 | | (21) a requirement that the managed care organization |
---|
202 | 177 | | demonstrate to the commission, before the organization begins to |
---|
203 | 178 | | provide health care services to recipients, that, subject to the |
---|
204 | 179 | | provider access standards established under Section 533.0061: |
---|
205 | 180 | | (A) the organization's provider network has the |
---|
206 | 181 | | capacity to serve the number of recipients expected to enroll in a |
---|
207 | 182 | | managed care plan offered by the organization; |
---|
208 | 183 | | (B) the organization's provider network |
---|
209 | 184 | | includes: |
---|
210 | 185 | | (i) a sufficient number of primary care |
---|
211 | 186 | | providers; |
---|
212 | 187 | | (ii) a sufficient variety of provider |
---|
213 | 188 | | types; |
---|
214 | 189 | | (iii) a sufficient number of providers of |
---|
215 | 190 | | long-term services and supports and specialty pediatric care |
---|
216 | 191 | | providers of home and community-based services; and |
---|
217 | 192 | | (iv) providers located throughout the |
---|
218 | 193 | | region where the organization will provide health care services; |
---|
219 | 194 | | and |
---|
220 | 195 | | (C) health care services will be accessible to |
---|
221 | 196 | | recipients through the organization's provider network to a |
---|
222 | 197 | | comparable extent that health care services would be available to |
---|
223 | 198 | | recipients under a fee-for-service or primary care case management |
---|
224 | 199 | | model of Medicaid managed care; |
---|
225 | 200 | | (22) a requirement that the managed care organization |
---|
226 | 201 | | develop a monitoring program for measuring the quality of the |
---|
227 | 202 | | health care services provided by the organization's provider |
---|
228 | 203 | | network that: |
---|
229 | 204 | | (A) incorporates the National Committee for |
---|
230 | 205 | | Quality Assurance's Healthcare Effectiveness Data and Information |
---|
235 | 207 | | (B) focuses on measuring outcomes; and |
---|
236 | 208 | | (C) includes the collection and analysis of |
---|
237 | 209 | | clinical data relating to prenatal care, preventive care, mental |
---|
238 | 210 | | health care, and the treatment of acute and chronic health |
---|
239 | 211 | | conditions and substance abuse; |
---|
240 | 212 | | (23) subject to Subsection (a-1), a requirement that |
---|
241 | 213 | | the managed care organization develop, implement, and maintain an |
---|
242 | 214 | | outpatient pharmacy benefit plan for its enrolled recipients: |
---|
243 | 215 | | (A) that, except as provided by Paragraph |
---|
244 | 216 | | (L)(ii), exclusively employs the vendor drug program formulary and |
---|
245 | 217 | | preserves the state's ability to reduce waste, fraud, and abuse |
---|
246 | 218 | | under Medicaid; |
---|
247 | 219 | | (B) that adheres to the applicable preferred drug |
---|
248 | 220 | | list adopted by the commission under Section 531.072; |
---|
249 | 221 | | (C) that, except as provided by Paragraph (L)(i), |
---|
250 | 222 | | includes the prior authorization procedures and requirements |
---|
251 | 223 | | prescribed by or implemented under Sections 531.073(b), (c), and |
---|
252 | 224 | | (g) for the vendor drug program; |
---|
253 | 225 | | (D) for purposes of which the managed care |
---|
254 | 226 | | organization: |
---|
255 | 227 | | (i) may not negotiate or collect rebates |
---|
256 | 228 | | associated with pharmacy products on the vendor drug program |
---|
257 | 229 | | formulary; and |
---|
258 | 230 | | (ii) may not receive drug rebate or pricing |
---|
259 | 231 | | information that is confidential under Section 531.071; |
---|
260 | 232 | | (E) that complies with the prohibition under |
---|
261 | 233 | | Section 531.089; |
---|
262 | 234 | | (F) under which the managed care organization may |
---|
263 | 235 | | not prohibit, limit, or interfere with a recipient's selection of a |
---|
264 | 236 | | pharmacy or pharmacist of the recipient's choice for the provision |
---|
265 | 237 | | of pharmaceutical services under the plan through the imposition of |
---|
266 | 238 | | different copayments; |
---|
267 | 239 | | (G) that allows the managed care organization or |
---|
268 | 240 | | any subcontracted pharmacy benefit manager to contract with a |
---|
269 | 241 | | pharmacist or pharmacy providers separately for specialty pharmacy |
---|
270 | 242 | | services, except that: |
---|
271 | 243 | | (i) the managed care organization and |
---|
272 | 244 | | pharmacy benefit manager are prohibited from allowing exclusive |
---|
273 | 245 | | contracts with a specialty pharmacy owned wholly or partly by the |
---|
274 | 246 | | pharmacy benefit manager responsible for the administration of the |
---|
275 | 247 | | pharmacy benefit program; and |
---|
276 | 248 | | (ii) the managed care organization and |
---|
277 | 249 | | pharmacy benefit manager must adopt policies and procedures for |
---|
278 | 250 | | reclassifying prescription drugs from retail to specialty drugs, |
---|
279 | 251 | | and those policies and procedures must be consistent with rules |
---|
280 | 252 | | adopted by the executive commissioner and include notice to network |
---|
281 | 253 | | pharmacy providers from the managed care organization; |
---|
282 | 254 | | (H) under which the managed care organization may |
---|
283 | 255 | | not prevent a pharmacy or pharmacist from participating as a |
---|
284 | 256 | | provider if the pharmacy or pharmacist agrees to comply with the |
---|
285 | 257 | | financial terms and conditions of the contract as well as other |
---|
286 | 258 | | reasonable administrative and professional terms and conditions of |
---|
287 | 259 | | the contract; |
---|
288 | 260 | | (I) under which the managed care organization may |
---|
289 | 261 | | include mail-order pharmacies in its networks, but may not require |
---|
290 | 262 | | enrolled recipients to use those pharmacies, and may not charge an |
---|
291 | 263 | | enrolled recipient who opts to use this service a fee, including |
---|
292 | 264 | | postage and handling fees; |
---|
293 | 265 | | (J) under which the managed care organization or |
---|
294 | 266 | | pharmacy benefit manager, as applicable, must pay claims in |
---|
295 | 267 | | accordance with Section 843.339, Insurance Code; [and] |
---|
296 | 268 | | (K) under which the managed care organization or |
---|
297 | 269 | | pharmacy benefit manager, as applicable: |
---|
298 | 270 | | (i) to place a drug on a maximum allowable |
---|
299 | 271 | | cost list, must ensure that: |
---|
300 | 272 | | (a) the drug is listed as "A" or "B" |
---|
301 | 273 | | rated in the most recent version of the United States Food and Drug |
---|
302 | 274 | | Administration's Approved Drug Products with Therapeutic |
---|
303 | 275 | | Equivalence Evaluations, also known as the Orange Book, has an "NR" |
---|
304 | 276 | | or "NA" rating or a similar rating by a nationally recognized |
---|
305 | 277 | | reference; and |
---|
306 | 278 | | (b) the drug is generally available |
---|
307 | 279 | | for purchase by pharmacies in the state from national or regional |
---|
308 | 280 | | wholesalers and is not obsolete; |
---|
309 | 281 | | (ii) must provide to a network pharmacy |
---|
310 | 282 | | provider, at the time a contract is entered into or renewed with the |
---|
311 | 283 | | network pharmacy provider, the sources used to determine the |
---|
312 | 284 | | maximum allowable cost pricing for the maximum allowable cost list |
---|
313 | 285 | | specific to that provider; |
---|
314 | 286 | | (iii) must review and update maximum |
---|
315 | 287 | | allowable cost price information at least once every seven days to |
---|
316 | 288 | | reflect any modification of maximum allowable cost pricing; |
---|
317 | 289 | | (iv) must, in formulating the maximum |
---|
318 | 290 | | allowable cost price for a drug, use only the price of the drug and |
---|
319 | 291 | | drugs listed as therapeutically equivalent in the most recent |
---|
320 | 292 | | version of the United States Food and Drug Administration's |
---|
321 | 293 | | Approved Drug Products with Therapeutic Equivalence Evaluations, |
---|
322 | 294 | | also known as the Orange Book; |
---|
323 | 295 | | (v) must establish a process for |
---|
324 | 296 | | eliminating products from the maximum allowable cost list or |
---|
325 | 297 | | modifying maximum allowable cost prices in a timely manner to |
---|
326 | 298 | | remain consistent with pricing changes and product availability in |
---|
327 | 299 | | the marketplace; |
---|
328 | 300 | | (vi) must: |
---|
329 | 301 | | (a) provide a procedure under which a |
---|
330 | 302 | | network pharmacy provider may challenge a listed maximum allowable |
---|
331 | 303 | | cost price for a drug; |
---|
332 | 304 | | (b) respond to a challenge not later |
---|
333 | 305 | | than the 15th day after the date the challenge is made; |
---|
334 | 306 | | (c) if the challenge is successful, |
---|
335 | 307 | | make an adjustment in the drug price effective on the date the |
---|
336 | 308 | | challenge is resolved[,] and make the adjustment applicable to all |
---|
337 | 309 | | similarly situated network pharmacy providers, as determined by the |
---|
338 | 310 | | managed care organization or pharmacy benefit manager, as |
---|
339 | 311 | | appropriate; |
---|
340 | 312 | | (d) if the challenge is denied, |
---|
341 | 313 | | provide the reason for the denial; and |
---|
342 | 314 | | (e) report to the commission every 90 |
---|
343 | 315 | | days the total number of challenges that were made and denied in the |
---|
344 | 316 | | preceding 90-day period for each maximum allowable cost list drug |
---|
345 | 317 | | for which a challenge was denied during the period; |
---|
346 | 318 | | (vii) must notify the commission not later |
---|
347 | 319 | | than the 21st day after implementing a practice of using a maximum |
---|
348 | 320 | | allowable cost list for drugs dispensed at retail but not by mail; |
---|
349 | 321 | | and |
---|
350 | 322 | | (viii) must provide a process for each of |
---|
351 | 323 | | its network pharmacy providers to readily access the maximum |
---|
352 | 324 | | allowable cost list specific to that provider; and |
---|
353 | 325 | | (L) under which the managed care organization or |
---|
354 | 326 | | pharmacy benefit manager, as applicable: |
---|
355 | 327 | | (i) may not require a prior authorization, |
---|
356 | 328 | | other than a clinical prior authorization or a prior authorization |
---|
357 | 329 | | imposed by the commission to minimize the opportunity for waste, |
---|
358 | 330 | | fraud, or abuse, for or impose any other barriers to a drug that is |
---|
359 | 331 | | prescribed to a child enrolled in the STAR Kids managed care program |
---|
360 | 332 | | for a particular disease or treatment and that is on the vendor drug |
---|
361 | 333 | | program formulary or require additional prior authorization for a |
---|
362 | 334 | | drug included in the preferred drug list adopted under Section |
---|
363 | 335 | | 531.072; |
---|
364 | 336 | | (ii) must provide for continued access to a |
---|
365 | 337 | | drug prescribed to a child enrolled in the STAR Kids managed care |
---|
366 | 338 | | program, regardless of whether the drug is on the vendor drug |
---|
367 | 339 | | program formulary or, if applicable on or after August 31, 2023, the |
---|
368 | 340 | | managed care organization's formulary; |
---|
369 | 341 | | (iii) may not use a protocol that requires a |
---|
370 | 342 | | child enrolled in the STAR Kids managed care program to use a |
---|
371 | 343 | | prescription drug or sequence of prescription drugs other than the |
---|
372 | 344 | | drug that the child's physician recommends for the child's |
---|
373 | 345 | | treatment before the managed care organization provides coverage |
---|
374 | 346 | | for the recommended drug; and |
---|
375 | 347 | | (iv) must pay liquidated damages to the |
---|
376 | 348 | | commission for each failure, as determined by the commission, to |
---|
377 | 349 | | comply with this paragraph in an amount that is a reasonable |
---|
378 | 350 | | forecast of the damages caused by the noncompliance; |
---|
379 | 351 | | (24) a requirement that the managed care organization |
---|
380 | 352 | | and any entity with which the managed care organization contracts |
---|
381 | 353 | | for the performance of services under a managed care plan disclose, |
---|
382 | 354 | | at no cost, to the commission and, on request, the office of the |
---|
383 | 355 | | attorney general all discounts, incentives, rebates, fees, free |
---|
384 | 356 | | goods, bundling arrangements, and other agreements affecting the |
---|
385 | 357 | | net cost of goods or services provided under the plan; |
---|
386 | 358 | | (25) a requirement that the managed care organization |
---|
387 | 359 | | not implement significant, nonnegotiated, across-the-board |
---|
388 | 360 | | provider reimbursement rate reductions unless: |
---|
389 | 361 | | (A) subject to Subsection (a-3), the |
---|
390 | 362 | | organization has the prior approval of the commission to make the |
---|
391 | 363 | | reductions [reduction]; or |
---|
392 | 364 | | (B) the rate reductions are based on changes to |
---|
393 | 365 | | the Medicaid fee schedule or cost containment initiatives |
---|
394 | 366 | | implemented by the commission; and |
---|
395 | 367 | | (26) a requirement that the managed care organization |
---|
396 | 368 | | make initial and subsequent primary care provider assignments and |
---|
397 | 369 | | changes. |
---|